CRISPR: Pursuit of profit poisons collaboration

Jacob S. Sherkow ()
Additional contact information
Jacob S. Sherkow: Jacob S. Sherkow is associate professor of law, Innovation Center for Law and Technology, New York Law School, New York, USA.

Nature, 2016, vol. 532, issue 7598, 172-173

Abstract: The CRISPR–Cas9 patent battle demonstrates how overzealous efforts to commercialize technology can damage science, writes Jacob S. Sherkow.

Date: 2016
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.nature.com/articles/532172a Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:nature:v:532:y:2016:i:7598:d:10.1038_532172a

Ordering information: This journal article can be ordered from
https://www.nature.com/

DOI: 10.1038/532172a

Access Statistics for this article

Nature is currently edited by Magdalena Skipper

More articles in Nature from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().